Sophie Lucas

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 7

Top Venues

Cancer immunology, immunotherapy : CII

Proceedings of the National Academy of Sciences of the United States of America

Science (New York, N.Y.)

Environmental microbiology

Université catholique de Louvain / de Duve Institute

Université catholique de Louvain (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Université catholique de Louvain / de Duve Institute Oct 01 2016

Belgium

Professor (and President of the de Duve Institute, since 2019)

F.R.S.-FNRS Oct 01 2008 - Oct 01 2016

Belgium

Research Associate :: de Duve Institute, Catholic University of Louvain

Education History

Université catholique de Louvain

Belgium

PHD :: de Duve Institute and Ludwig Institute for Cancer research

Publications

Sara Lecomte, Julien Devreux, Grégoire de Streel, Nicolas van Baren, Violaine Havelange, David Schröder, Noora Vaherto, Christophe Vanhaver, Christophe Vanderaa, Noémie Dupuis, Christian Pecquet, Pierre G Coulie, Stefan N Constantinescu, Sophie Lucas
Therapeutic activity of GARP:TGF-β1 blockade in murine primary myelofibrosis. Blood (2022)
Mélanie Gaignage, Xuhao Zhang, Julie Stockis, Olivier Dedobbeleer, Camille Michiels, Perrine Cochez, Laure Dumoutier, Pierre G Coulie, Sophie Lucas
Blocking GARP-mediated activation of TGF-β1 did not alter innate or adaptive immune responses to bacterial infection or protein immunization in mice. Cancer immunology, immunotherapy : CII 71 (8) (2022)
Grégoire de Streel, Charlotte Bertrand, Nicolas Chalon, Stéphanie Liénart, Orian Bricard, Sara Lecomte, Julien Devreux, Mélanie Gaignage, Gitte De Boeck, Lore Mariën, Inge Van De Walle, Bas van der Woning, Michael Saunders, Hans de Haard, Elien Vermeersch, Wim Maes, Hans Deckmyn, Pierre G Coulie, Nicolas van Baren, Sophie Lucas
Selective inhibition of TGF-β1 produced by GARP-expressing Tregs overcomes resistance to PD-1/PD-L1 blockade in cancer. Nature communications 11 (1) (2020)
Jean Armengaud, Agnès Delaunay-Moisan, Jean-Yves Thuret, Eelco van Anken, Diego Acosta-Alvear, Tomás Aragón, Carolina Arias, Marc Blondel, Ineke Braakman, Jean-François Collet, René Courcol, Antoine Danchin, Jean François Deleuze, Jean-Philippe Lavigne, Sophie Lucas, Thomas Michiels, Edward R B Moore, Jonathon Nixon-Abell, Ramon Rosselló-Móra, Zheng-Li Shi, Antonio G Siccardi, Roberto Sitia, Daniel Tillett, Kenneth N Timmis, Michel B Toledano, Peter van der Sluijs, Elisa Vicenzi
The importance of naturally attenuated SARS-CoV-2in the fight against COVID-19. Environmental microbiology 22 (6) (2020)
Stephanie Lienart, Romain Merceron, Christophe Vanderaa, Fanny Lambert, Didier Colau, Julie Stockis, Bas van der Woning, Hans De Haard, Michael Saunders, Pierre G Coulie, Savvas N Savvides, Sophie Lucas
Structural basis of latent TGF-β1 presentation and activation by GARP on human regulatory T cells. Science (New York, N.Y.) 362 (6417) (2018)
Olivier Dedobbeleer, Julie Stockis, Bas van der Woning, Pierre G Coulie, Sophie Lucas
Cutting Edge: Active TGF-β1 Released from GARP/TGF-β1 Complexes on the Surface of Stimulated Human B Lymphocytes Increases Class-Switch Recombination and Production of IgA. Journal of immunology (Baltimore, Md. : 1950) 199 (2) (2017)
Julie Stockis, Stéphanie Liénart, Didier Colau, Amandine Collignon, Stephen L Nishimura, Dean Sheppard, Pierre G Coulie, Sophie Lucas
Blocking immunosuppression by human Tregs in vivo with antibodies targeting integrin αVβ8. Proceedings of the National Academy of Sciences of the United States of America 114 (47) (2017)

Sophie Lucas.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Sophie Lucas